Senior insider sale
CEO - Elect at TAKEDA PHARMACEUTICAL CO LTD — senior position signals high conviction
$1.62M
96.56K shares
What this filing means
KIM JULIE SO-YOUNG plans to sell 96.56K shares of TAKEDA PHARMACEUTICAL CO LTD valued at approximately $1.62M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 7/13/2026ACC: 0001395064-26-000299
Officer· CEO - Elect
Since Mar 2026
96.56K
Shares to sell
$1.62M
Approx. market value
190.41K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Restricted Stock Unit Awards - Vested.
Compensation
7/1/2026
190.41KTotal acquired190.41K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
7/1/2026 | Restricted Stock Unit Awards - Vested. Compensation | 190.41K | — |
| Total | 190.41K | ||
Planned & Completed Dispositions1
NYSEPlanned
Units to sell
96.56K
Market value
$1.62M
7/13/2026
Total
Units
96.56K
Value
$1.62M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
7/13/2026 | 96.56K | $1.62M | NYSE | Planned |
| Total | 96.56K | $1.62M | ||